Jonathan C. Zhao

3.6k total citations
34 papers, 2.5k citations indexed

About

Jonathan C. Zhao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jonathan C. Zhao has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Jonathan C. Zhao's work include Prostate Cancer Treatment and Research (21 papers), Epigenetics and DNA Methylation (7 papers) and Cancer-related gene regulation (6 papers). Jonathan C. Zhao is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Epigenetics and DNA Methylation (7 papers) and Cancer-related gene regulation (6 papers). Jonathan C. Zhao collaborates with scholars based in United States, China and Canada. Jonathan C. Zhao's co-authors include Jindan Yu, Jung Kim, Ka-wing Fong, Yeqing Angela Yang, Bing Song, Hongjian Jin, Longtao Wu, Xiaodong Lü, Aihua Zhang and Jian Yu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan C. Zhao

33 papers receiving 2.5k citations

Peers

Jonathan C. Zhao

PRM

ONCOL

GENET

Ram S. Mani United States

Eijiro Nakamura Japan

Meena Augustus United States

Giulia Bottai Italy

Yanis Boumber United States

Sunita Shankar United States

Beth E. Helgeson United States

James V. Alvarez United States

Youngsoo Kim United States

Yong Sung Kim South Korea

Ram S. Mani United States

Jonathan C. Zhao

1.9k ×1.0

951 ×0.9

494 ×0.6

PRM

358 ×0.9

ONCOL

188 ×0.9

GENET

Citations per year, relative to Jonathan C. Zhao Jonathan C. Zhao (= 1×) peers Ram S. Mani

Countries citing papers authored by Jonathan C. Zhao

Since Specialization

Citations

This map shows the geographic impact of Jonathan C. Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan C. Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan C. Zhao more than expected).

Fields of papers citing papers by Jonathan C. Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan C. Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan C. Zhao. The network helps show where Jonathan C. Zhao may publish in the future.

Co-authorship network of co-authors of Jonathan C. Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan C. Zhao. A scholar is included among the top collaborators of Jonathan C. Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan C. Zhao. Jonathan C. Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lü, Xiaodong, Wanqing Xie, Galina Gritsina, et al.. (2025). NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling. Nature Genetics. 57(8). 1966–1980. 1 indexed citations

Lin, Zhuoyuan, Shivani Agarwal, Song Tan, et al.. (2023). Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. Oncogene. 42(26). 2126–2138. 15 indexed citations

Gritsina, Galina, Ka-wing Fong, Xiaodong Lü, et al.. (2023). Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. Journal of Clinical Investigation. 133(15). 17 indexed citations

Lü, Xiaodong, Ka-wing Fong, Galina Gritsina, et al.. (2022). HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature Genetics. 54(5). 670–683. 58 indexed citations

Fong, Ka-wing, Jonathan C. Zhao, Xiaodong Lü, et al.. (2022). PALI1 promotes tumor growth through competitive recruitment of PRC2 to G9A-target chromatin for dual epigenetic silencing. Molecular Cell. 82(24). 4611–4626.e7. 17 indexed citations

Fong, Ka-wing, Jung Kim, Xiaodong Lü, et al.. (2021). Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. Science Advances. 7(15). 46 indexed citations

Li, Shangze, Ka-wing Fong, Galina Gritsina, et al.. (2019). Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 79(10). 2580–2592. 92 indexed citations

Zhu, Sen, Dongyu Zhao, Yan Lin, et al.. (2018). BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1. Nature Communications. 9(1). 500–500. 63 indexed citations

Putzbach, William, Quan Q. Gao, Monal Patel, et al.. (2017). Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism. eLife. 6. 46 indexed citations

10.

Kim, Jung, Hongjian Jin, Jonathan C. Zhao, et al.. (2017). FOXA1 inhibits prostate cancer neuroendocrine differentiation. Oncogene. 36(28). 4072–4080. 106 indexed citations

11.

Zhao, Jonathan C., Xingyao Li, Mingxiong Guo, Jindan Yu, & Chunhong Yan. (2016). The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics. 17(1). 335–335. 87 indexed citations

12.

Yang, Yeqing Angela, Jonathan C. Zhao, Ka-wing Fong, et al.. (2016). FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function. Nucleic Acids Research. 44(17). 8153–8164. 51 indexed citations

13.

Zhao, Jonathan C., Ka-wing Fong, Hongjian Jin, et al.. (2016). FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression. Oncogene. 35(33). 4335–4344. 48 indexed citations

14.

Xue, Xiangyang, Yeqing Angela Yang, Aihua Zhang, et al.. (2015). LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 35(21). 2746–2755. 357 indexed citations

15.

Jin, Hongjian, Jonathan C. Zhao, Longtao Wu, Jung Kim, & Jindan Yu. (2014). Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Nature Communications. 5(1). 3972–3972. 134 indexed citations

16.

Jin, Hongjian, Jonathan C. Zhao, Irene Ogden, Raymond C. Bergan, & Jindan Yu. (2013). Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis. Cancer Research. 73(12). 3725–3736. 117 indexed citations

17.

Wu, Longtao, Jonathan C. Zhao, Jung Kim, et al.. (2013). ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer. Cancer Research. 73(19). 6068–6079. 65 indexed citations

18.

Wang, Lan, Shuai Chen, Liya Ding, et al.. (2013). BRCA1 is a negative modulator of the PRC2 complex. The EMBO Journal. 32(11). 1584–1597. 92 indexed citations

19.

Kim, Jung, Longtao Wu, Jonathan C. Zhao, Hongjian Jin, & Jindan Yu. (2013). TMPRSS2–ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c. Oncogene. 33(44). 5183–5192. 40 indexed citations

20.

Zhao, Jonathan C., Jianjun Yu, Longtao Wu, et al.. (2011). Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Research. 22(2). 322–331. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact